Associated Papers
The targeted next-generation sequence revealed SMAD4, AKT1, and TP53 mutations from circulating cell-free DNA of breast cancer and its effect on protein structure - A computational approach.
Balasundaram A et al.
Journal of Biomolecular Structure & Dynamics, 2023
CHK1-targeted therapy to deplete DNA replication-stressed, p53-deficient, hyperdiploid colorectal cancer stem cells.
Manic G et al.
Gut, 2018
28389531 (PubMed )
Supplement: gutjnl-2016-312623supp002.pdf
Germline mutations in SMAD4 disrupt bone morphogenetic protein signaling.
Carr JC et al.
The Journal of Surgical Research, 2012
Select a paper to view details